RESEARCH · GHK-CU
GHK-Cu 50mg Research Vial: Copper-Peptide Chemistry and Laboratory Findings
GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine (GHK). It is one of the most widely discussed copper peptides in cell-biology and dermatology research. This article looks at it as a laboratory material: its chemistry, the published cell and animal findings, and the open questions. PurixLab’s GHK-Cu 50mg is a lyophilized research vial for laboratory use only. It is a separate product from our finished cosmetic, Copper Facial Mask; see how the two differ.
Discovery and natural occurrence
Loren Pickart first described GHK in 1973 as a tripeptide in human serum that prolonged the survival of normal liver cells and stimulated growth in neoplastic liver cells [1]. Later reviews describe it as an activity first found in human albumin that caused old liver tissue to synthesise proteins in a pattern resembling younger tissue, and note its high affinity for copper ions [2]. GHK occurs in human blood, and its levels are reported to decline with age [3].
Copper-binding chemistry
- Solution species. Potentiometric and spectrophotometric work across pH 3.5–10.6 found multiple Cu(II)–GHK species in solution. The ε-amino group of lysine enhanced complex stability compared with Gly-His or Gly-His-Gly [4].
- Competition with albumin. In equilibrium-dialysis experiments, GHK competed with albumin for Cu(II): at equimolar albumin and peptide, about 42% of the copper was bound to the peptide. At physiologically relevant concentrations, about 6% of Cu(II) was associated with low-molecular-weight components. The authors discussed a possible role in transporting copper from blood to tissues [4].
- Structure. X-ray and spectroscopic analysis showed that [Cu(II)(GHK)] is dimeric in the solid state but monomeric in solution, coordinated by three nitrogen ligands: the terminal amine, an amide nitrogen and the histidine imidazole. Copper exchange is fast, and the complex is redox-inert under moderate potentials but can be reduced to Cu(I), with release of the copper ion, at about −0.62 V versus Ag/AgCl [5].
The practical point for experiment design is that GHK and GHK-Cu are not interchangeable. In dermal fibroblasts, GHK-Cu increased MMP-2 levels, an effect reproduced by copper ions but not by the GHK peptide alone [6].
Extracellular-matrix and fibroblast studies
- Collagen synthesis. GHK-Cu stimulated collagen synthesis in fibroblast cultures. The effect began at 10−12–10−11 M, peaked around 10−9 M and was independent of cell number [7].
- Matrix remodelling enzymes. In cultured fibroblasts, GHK-Cu raised MMP-2 protein and mRNA as well as secretion of the inhibitors TIMP-1 and TIMP-2. The authors concluded that it modulates both matrix production and matrix remodelling [6].
- Wound chambers in rats. In subcutaneous wound chambers, GHK-Cu increased pro- and activated MMP-2 in the later stages of healing [8], and increased glycosaminoglycans and decorin expression while lowering biglycan [9].
Animal wound models
In a study of 24 rats with ischaemic open wounds, a topical tripeptide-copper complex gel reduced initial wound area by 64.5% at day 13, compared with 45.6% for the vehicle gel and 28.2% for untreated controls. Treated wounds also had lower TNF-α, MMP-2 and MMP-9 concentrations [10]. This was a single rodent study of one commercial formulation.
Gene-expression research
Campbell and colleagues profiled lung tissue from smokers with COPD and identified a gene-expression signature linked to emphysema severity. Using the Connectivity Map database, they identified GHK as a compound predicted to reverse that signature. In follow-up experiments, GHK induced TGF-β-like expression patterns in human fibroblasts, organised the actin cytoskeleton, raised integrin β1 expression, and restored collagen-gel contraction by fibroblasts derived from COPD lungs [11]. Pickart and Margolina’s 2018 review discusses newer gene-expression data suggesting that GHK is linked to multiple biochemical pathways [12]. These are mostly computational associations and cell experiments, not clinical outcomes.
What remains unknown
- Human evidence. A 2026 review of unapproved peptides marketed directly to patients, which included GHK-Cu, concluded that rigorous human safety data are scarce [13].
- Peptide vs copper. Some effects attributed to GHK-Cu may be driven by the copper itself [6]. Experiments often need GHK-only and copper-only controls.
- Source of the literature. Many of the broad reviews are written by GHK’s discoverer and colleagues [14,2,12]. Independent mechanistic replication is useful.
- Model dependence. Results depend on cell type, concentration, vehicle and model, so findings from one system do not automatically transfer to another.
General laboratory storage background
Laboratories should always follow the product label, any batch documentation and their own approved procedures. As general background, peptide suppliers’ technical guides describe broadly similar practice for lyophilized (freeze-dried) peptides:
- Dry, dark and cold. Store lyophilized peptides away from heat, light and moisture; about −20 °C is commonly recommended for longer-term storage [15,16].
- Moisture uptake. GenScript notes that peptides containing His or Lys are prone to absorbing moisture from the air and are best kept in a desiccator in a tightly capped vial [15]. GHK contains both.
- Avoid condensation. Let a cold vial reach room temperature before opening, then reseal promptly [16].
- Limit freeze–thaw and solution storage. Aliquot by planned experiment; peptides in solution have a much shorter shelf life than the dry powder [15,16].
This is general laboratory information, not a protocol, and it contains no instructions for human use.
GHK-Cu 50mg at PurixLab
GHK-Cu 50mg: a labelled lyophilized research vial with 50mg per vial, C$49 per vial (CAD, before tax), for laboratory research only. It is not a cosmetic; our separate Copper Facial Mask is the finished cosmetic product. GHK-Cu is also one of three components of GLOW BLEND 70mg.
PurixLab ships within Canada only, from stock held in Toronto. Standard shipping is C$15, and shipping is free when the product subtotal is C$200 or more after discounts. Orders outside the GTA ship by Canada Post Xpresspost. Prices are in CAD and taxes are calculated from your shipping address at checkout.
In Toronto and the GTA, our own team delivers orders the same day or the next day. There is no fixed GTA delivery fee: after you place your order, we email you to confirm the delivery time and any delivery charge, and then you pay. There is no storefront or local pickup.
Payment is by Interac e-Transfer (instructions are shown at checkout) or by cryptocurrency through Plisio (Bitcoin, Ethereum, USDT and more): choose Plisio at checkout and you are sent to a secure Plisio payment page after placing the order. Codes: WELCOME10 takes 10% off eligible orders below C$400; PURIX20 takes 20% off eligible orders of C$400 or more before discount and tax. One offer per order; offers do not stack.
For laboratory research use only. Not for human or veterinary use, not for consumption, injection or application to skin, and purchasers must be 18 or older. The studies summarised above describe specific materials in published research; they are not claims about any PurixLab product.
Questions or batch documentation requests: [email protected] · Shipping & Delivery · Toronto & GTA delivery · PurixLab FAQ
References
- Pickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nat New Biol. 1973;243(124):85-7. PubMed 4349963
- Pickart L, Vasquez-Soltero JM, Margolina A. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health. Oxid Med Cell Longev. 2012;2012:324832. PubMed 22666519 · PMC3359723 · doi:10.1155/2012/324832
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK and DNA: resetting the human genome to health. Biomed Res Int. 2014;2014:151479. PubMed 25302294 · PMC4180391 · doi:10.1155/2014/151479
- Lau SJ, Sarkar B. The interaction of copper(II) and glycyl-L-histidyl-L-lysine, a growth-modulating tripeptide from plasma. Biochem J. 1981;199(3):649-56. PubMed 7340824 · PMC1163421 · doi:10.1042/bj1990649
- Hureau C, Eury H, Guillot R, et al. X-ray and solution structures of Cu(II) GHK and Cu(II) DAHK complexes: influence on their redox properties. Chemistry. 2011;17(36):10151-60. PubMed 21780203 · doi:10.1002/chem.201100751
- Siméon A, Emonard H, Hornebeck W, Maquart FX. The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci. 2000;67(18):2257-65. PubMed 11045606 · doi:10.1016/s0024-3205(00)00803-1
- Maquart FX, Pickart L, Laurent M, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988;238(2):343-6. PubMed 3169264 · doi:10.1016/0014-5793(88)80509-x
- Siméon A, Monier F, Emonard H, et al. Expression and activation of matrix metalloproteinases in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. J Invest Dermatol. 1999;112(6):957-64. PubMed 10383745 · doi:10.1046/j.1523-1747.1999.00606.x
- Siméon A, Wegrowski Y, Bontemps Y, et al. Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu(2+). J Invest Dermatol. 2000;115(6):962-8. PubMed 11121126 · doi:10.1046/j.1523-1747.2000.00166.x
- Canapp SO Jr, Farese JP, Schultz GS, et al. The effect of topical tripeptide-copper complex on healing of ischemic open wounds. Vet Surg. 2003;32(6):515-23. PubMed 14648529 · doi:10.1111/j.1532-950x.2003.00515.x
- Campbell JD, McDonough JE, Zeskind JE, et al. A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK. Genome Med. 2012;4(8):67. PubMed 22937864 · PMC4064320 · doi:10.1186/gm367
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. PubMed 29986520 · PMC6073405 · doi:10.3390/ijms19071987
- Mendias CL, Awan TM. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Med. 2026;56(8):1921-1935. PubMed 41966639 · doi:10.1007/s40279-026-02437-0
- Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-88. PubMed 18644225 · doi:10.1163/156856208784909435
- GenScript. Peptide Storage and Handling Guidelines (technical resource). GenScript
- AAPPTec. Handling and Storage of Peptides — FAQ (technical resource). AAPPTec